Literature DB >> 2767004

Properties of isolated nonciliated bronchiolar cells from mouse lung.

S R Walker1, S Hale, A M Malkinson, R J Mason.   

Abstract

Nonciliated bronchiolar cells (Clara cells) are thought to provide important respiratory secretions in the small airways and to have other metabolic functions. In mice, nonciliated bronchiolar cells have been the subject of special investigation because tumors of these cells can be specifically induced by chemical carcinogens. A method for isolating nonciliated bronchiolar cells from mice has been reported. However, we have developed a method to isolate these cells from the lungs of BDF1 mice with approximately 80% purity. Cells were identified by electron microscopy, nitroblue tetrazolium dye reduction in the presence of NADPH, immunocytochemical staining of cytochrome P450 isozymes, and mitochondrial staining with rhodamine 123. The isolated cells were examined in culture for synthesis and secretion of proteins and phospholipids. Protein synthesis and secretion were examined in cells labeled with [34S]methionine for 16 h. Fresh medium was added to washed cells and the cells were incubated for an additional 3h. The secreted proteins were precipitated with 10% trichloroacetic acid. Molecular weights of the most prominent radiolabeled secreted proteins were 6, 36, 43, and 45 kDa. Phospholipid synthesis and secretion were examined in cells labeled with [14C]acetate and 32P. Less than 1% of the radioactive lipids was found in the medium, and secretion of lipid was not stimulated by terbutaline or tetradecanoylphorbol acetate compounds, which stimulate phospholipid secretion by type II cells. These data support the hypothesis that nonciliated bronchiolar cells synthesize and secrete proteins but do not secrete phospholipids in any appreciable amount.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767004     DOI: 10.3109/01902148909069618

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  8 in total

1.  Troglitazone-activated PPARγ inhibits LPS-induced lung alveolar type II epithelial cells injuries via TNF-α.

Authors:  Bo Xiao; Jing Xu; Guansong Wang; Peng Jiang; Fang Fang; Jian Huang; Jianchun Wang
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

2.  An improved method for the isolation of type II and Clara cells from mice.

Authors:  S A Belinsky; J F Lechner; N F Johnson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-05       Impact factor: 2.416

3.  Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.

Authors:  David J Blake; Anju Singh; Ponvijay Kombairaju; Deepti Malhotra; Thomas J Mariani; Rubin M Tuder; Edward Gabrielson; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

4.  Thoughts on the alveolar phase of COVID-19.

Authors:  Robert J Mason
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-03       Impact factor: 5.464

5.  Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.

Authors:  Eloïse Raoust; Viviane Balloy; Ignacio Garcia-Verdugo; Lhousseine Touqui; Reuben Ramphal; Michel Chignard
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

6.  Novel method for isolation of murine clara cell secretory protein-expressing cells with traces of stemness.

Authors:  Xiao-Yang Wang; Kathleen M Keefe; Sandra M Jensen-Taubman; Danlei Yang; Kai Yan; R Ilona Linnoila
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

Review 7.  Genetic studies on lung tumor susceptibility and histogenesis in mice.

Authors:  A M Malkinson
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

8.  Clara cell adhesion and migration to extracellular matrix.

Authors:  Jeffrey J Atkinson; Tracy L Adair-Kirk; Diane G Kelley; Daphne Demello; Robert M Senior
Journal:  Respir Res       Date:  2008-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.